M&A Deal Summary

MINAPHARM Pharmaceuticals SAE Acquires ProBioGen AG

On June 14, 2010, MINAPHARM Pharmaceuticals SAE acquired life science company ProBioGen AG from SHS Capital for 30M EUR

Acquisition Highlights
  • This is MINAPHARM Pharmaceuticals SAE’s 1st transaction in the Life Science sector.
  • This is MINAPHARM Pharmaceuticals SAE’s largest (disclosed) transaction.
  • This is MINAPHARM Pharmaceuticals SAE’s 1st transaction in Germany.

M&A Deal Summary
Date 2010-06-14
Target ProBioGen AG
Sector Life Science
Buyer(s) MINAPHARM Pharmaceuticals SAE
Sellers(s) SHS Capital
Deal Type Add-on Acquisition
Deal Value 30M EUR

Target

ProBioGen AG

Berlin, Germany
ProBioGen AG optimization of mammalian cell lines for production and manufacturing of recombinant proteins.

Search 201,839 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

MINAPHARM Pharmaceuticals SAE

Cairo, Egypt
Category Company
Sector Life Science
DESCRIPTION

MINAPHARM Pharmaceuticals SAE maintains one of the broadest quality-products portfolio within the industry.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

SHS Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
Size Small
Type Sector Focused
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.

DEAL STATS #
Overall 3 of 17
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 1 of 10
Country (Germany) 2 of 13
Year (2010) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-12 TNI medical AG

Wurzburg, Germany

TNI medical AG is into the development, production, and sale of diagnostic and therapeutic devices in the area of breathing support for the home-care and clinic area. TNI medical was founded in 2007 and is based in Wurzburg, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-30 phenox

Bochum, Germany

phenox is a provider of neurovascular products. phenox's portfolio of products trans-catheter-based neurovascular interventions (treatment of ischemic as well as hemorrhagic stroke patients). The comprehensive product range (stent retriever, flow diverter, aspiration catheter, access, coil, balloon, etc.) is sold worldwide. phenox was founded in 2005 and is based in Bochum, Germany.

Buy -
Mergr

Product

Company

Legal